ES547962A0 - Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central - Google Patents

Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central

Info

Publication number
ES547962A0
ES547962A0 ES547962A ES547962A ES547962A0 ES 547962 A0 ES547962 A0 ES 547962A0 ES 547962 A ES547962 A ES 547962A ES 547962 A ES547962 A ES 547962A ES 547962 A0 ES547962 A0 ES 547962A0
Authority
ES
Spain
Prior art keywords
derivatives
group
nervous system
central nervous
tiadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547962A
Other languages
English (en)
Other versions
ES8605269A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8605269A1 publication Critical patent/ES8605269A1/es
Publication of ES547962A0 publication Critical patent/ES547962A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
ES547962A 1984-10-18 1985-10-17 Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central Expired ES8605269A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8415991A FR2572074B1 (fr) 1984-10-18 1984-10-18 Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
ES8605269A1 ES8605269A1 (es) 1986-03-16
ES547962A0 true ES547962A0 (es) 1986-03-16

Family

ID=9308790

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547962A Expired ES8605269A1 (es) 1984-10-18 1985-10-17 Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central

Country Status (16)

Country Link
US (1) US4596802A (es)
EP (1) EP0183577B1 (es)
JP (1) JPS6197274A (es)
KR (1) KR860003245A (es)
AT (1) ATE50253T1 (es)
AU (1) AU577159B2 (es)
CA (1) CA1259990A (es)
DE (1) DE3575923D1 (es)
DK (1) DK469285A (es)
ES (1) ES8605269A1 (es)
FR (1) FR2572074B1 (es)
GR (1) GR852530B (es)
IL (1) IL76652A0 (es)
NZ (1) NZ213865A (es)
PT (1) PT81314B (es)
ZA (1) ZA858030B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625774D0 (en) * 1986-10-28 1986-12-03 Reckitt & Colmann Prod Ltd Thiadiazole derivative
FR2636628B1 (fr) * 1988-08-25 1990-12-28 Sanofi Sa Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
IT1255219B (it) * 1992-07-14 1995-10-20 Ct Lab Farm Srl Derivati del tiadiazolo per la cura degli stati depressivi
EA012181B1 (ru) * 2004-10-18 2009-08-28 Амген, Инк. Соединения тиадиазола и их применение
AU2008276512A1 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of PKB

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053085A (es) * 1964-03-26
FR2092714B1 (es) * 1970-06-11 1974-03-22 Melle Bezons
US3919428A (en) * 1972-01-17 1975-11-11 Sandoz Ag 2-Amino-5-(substituted or unsubstituted phenylalkyl)1,3,4-thiadiazoles for treating anxiety

Also Published As

Publication number Publication date
IL76652A0 (en) 1986-02-28
DK469285A (da) 1986-04-19
ZA858030B (en) 1986-06-25
AU4848085A (en) 1986-04-24
PT81314B (pt) 1987-11-30
ES8605269A1 (es) 1986-03-16
PT81314A (fr) 1985-11-01
EP0183577B1 (fr) 1990-02-07
DK469285D0 (da) 1985-10-14
FR2572074A1 (fr) 1986-04-25
KR860003245A (ko) 1986-05-21
US4596802A (en) 1986-06-24
EP0183577A1 (fr) 1986-06-04
NZ213865A (en) 1988-05-30
DE3575923D1 (de) 1990-03-15
GR852530B (es) 1986-02-19
AU577159B2 (en) 1988-09-15
CA1259990A (en) 1989-09-26
ATE50253T1 (de) 1990-02-15
JPS6197274A (ja) 1986-05-15
FR2572074B1 (fr) 1987-07-17

Similar Documents

Publication Publication Date Title
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
ES512842A0 (es) "procedimiento de preparar derivados carboxamidicos".
ES539446A0 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
ES552593A0 (es) Un procedimiento para preparar derivados de aminoacidos
DK161382C (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
GB8401093D0 (en) Cephem compounds
ES528561A0 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
FI881816A0 (fi) Nya bicykliska foereningar, foerfarane foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
ES547962A0 (es) Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central
NO852514L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater.
AU7529487A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
PT84680B (pt) Processo para a preparacao de derivados de 1,5-benzotiazepina e de composicoes farmaceuticas que os contem
FI853866A0 (fi) 2-pyridin-tiol-derivat, foerfarande foer framstaellning av dessa samt farmaceutiska foereningar innehaollande dessa.
SE8303719L (sv) Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
ES543799A0 (es) Procedimiento de preparacion de nuevos derivados 1-hidroxi- propilresorcinos provistos de un grupo fenilo sustituido
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8303718L (sv) E-homo-enurnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
ES489925A1 (es) Procedimiento para la preparacion de n,n'-difenil-monohidra-zida de acido 2-(3-metil-3-butenil)-malonico
ES534033A0 (es) Procedimiento para la preparacion de derivados de acridanona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401